Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Tactile Systems Technology, Inc. TCMD

Healthcare  —  Medical Devices
22.73 (0.16) (0.70%) as of 25 Sep
Market cap
$518.5M
P/E
20.7×
Cash Flow Champion (3y) Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Tactile Systems Technology, Inc. (TCMD) Business Profile

Updated before January 2025

Company Overview

Tactile Systems Technology, Inc. (TCMD), commonly referred to as Tactile Medical, is a leading medical technology company specializing in at-home therapy solutions for patients with chronic diseases. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota, USA. Over the years, Tactile Medical has established itself as a pioneer in developing innovative medical devices that improve the quality of life for patients suffering from lymphedema, chronic venous insufficiency, and other related conditions.

The company is led by a team of experienced professionals. As of the latest update, the CEO and President is Daniel L. Reuvers, who joined the company in 2020. Under his leadership, Tactile Medical has continued to expand its product portfolio and strengthen its market presence. The company’s board of directors and executive team bring a wealth of expertise in healthcare, medical technology, and business management, ensuring a strong strategic direction.

Core Business Segments

Tactile Medical operates primarily in the medical device industry, focusing on non-invasive, at-home therapeutic solutions. The company’s core business segments include:

1. Lymphedema Treatment

Tactile Medical’s flagship product in this category is the Flexitouch® Plus System, a pneumatic compression device designed to treat lymphedema. This system helps reduce swelling and improve lymphatic flow, providing significant relief to patients. The Flexitouch® Plus is widely recognized for its effectiveness and ease of use, making it a preferred choice among healthcare providers and patients.

2. Chronic Venous Insufficiency (CVI) Management

The company offers the Entre™ System, a pneumatic compression device aimed at managing symptoms of chronic venous insufficiency. This product is designed to improve circulation and reduce swelling in patients with venous disorders. The Entre™ System is particularly beneficial for patients who require ongoing therapy to manage their condition.

3. Post-Surgical and Injury Recovery

Tactile Medical also provides solutions for post-surgical and injury recovery. These products are designed to enhance healing, reduce swelling, and improve patient outcomes. While this segment is not as prominent as the lymphedema and CVI categories, it represents a growing area of focus for the company.

Business Model

Tactile Medical’s business model revolves around the development, manufacturing, and distribution of innovative medical devices. The company primarily generates revenue through the sale of its products to healthcare providers, patients, and insurance companies. Key aspects of its business model include:

  • Direct-to-Patient Approach: Tactile Medical emphasizes a direct-to-patient model, ensuring that its products are accessible and easy to use in a home setting. This approach enhances patient compliance and satisfaction.
  • Insurance Reimbursement: A significant portion of the company’s revenue comes from insurance reimbursements. Tactile Medical works closely with insurance providers to ensure coverage for its products, making them more affordable for patients.
  • Clinical Support Services: The company offers comprehensive clinical support services, including patient education, device training, and ongoing support. These services are integral to the company’s value proposition and help differentiate it from competitors.

Strategic Direction

Tactile Medical is focused on expanding its market presence and driving long-term growth. Key elements of its strategic direction include:

  • Product Innovation: The company is committed to developing new and improved products to address unmet medical needs. This includes exploring advanced technologies and expanding its product portfolio.
  • Market Expansion: Tactile Medical aims to increase its penetration in existing markets while exploring opportunities in new geographic regions. This includes strengthening relationships with healthcare providers and insurance companies.
  • Sustainability Goals: The company is dedicated to promoting sustainability in its operations. This includes reducing its environmental footprint and adopting eco-friendly manufacturing practices.
  • Patient-Centric Approach: Tactile Medical continues to prioritize patient outcomes by enhancing the usability and effectiveness of its products.

Competitive Landscape

Tactile Medical operates in a competitive market, facing competition from both established players and emerging companies. Key competitors include:

  • Bio Compression Systems: A leading provider of pneumatic compression devices for lymphedema and venous disorders.
  • Lympha Press®: Known for its advanced compression therapy systems, Lympha Press® is a strong competitor in the lymphedema treatment market.
  • Devon Medical Products: Offers a range of medical devices, including compression therapy systems.
  • Medtronic: While not a direct competitor in all segments, Medtronic’s broad portfolio of medical devices poses indirect competition.

Risk Factors

Tactile Medical faces several risks that could impact its business operations and financial performance. Key risk factors include:

  • Market Dependence: The company relies heavily on the success of its core products, particularly the Flexitouch® Plus System. Any decline in demand for these products could adversely affect revenue.
  • Regulatory Challenges: As a medical device manufacturer, Tactile Medical is subject to stringent regulatory requirements. Changes in regulations or delays in product approvals could impact the company’s operations.
  • Supply Chain Disruptions: The company’s reliance on third-party suppliers for components exposes it to supply chain risks, including delays and cost fluctuations.
  • Insurance Reimbursement: Changes in insurance reimbursement policies could affect the affordability and accessibility of the company’s products.

Recent Developments

Tactile Medical has made significant strides in recent years, including:

  • Product Enhancements: The company has introduced updates to its Flexitouch® Plus System, incorporating advanced features to improve patient outcomes.
  • Strategic Partnerships: Tactile Medical has formed partnerships with healthcare providers and organizations to expand its reach and enhance patient care.
  • Global Developments: The COVID-19 pandemic highlighted the importance of at-home therapy solutions, driving increased demand for the company’s products. Tactile Medical has adapted to this trend by enhancing its direct-to-patient model.

Investment Considerations

Investors considering Tactile Medical should weigh the following factors:

Strengths

  • Market Leadership: Tactile Medical is a leader in the lymphedema treatment market, with a strong brand and reputation.
  • Innovative Products: The company’s focus on innovation positions it well for long-term growth.
  • Growing Demand: The increasing prevalence of chronic diseases supports the demand for Tactile Medical’s products.

Risks

  • Market Concentration: The company’s reliance on a few key products makes it vulnerable to market fluctuations.
  • Regulatory Risks: Compliance with regulatory requirements is critical and poses ongoing challenges.
  • Competitive Pressure: The presence of strong competitors could impact market share and pricing.

Conclusion

Tactile Systems Technology, Inc. is a prominent player in the medical device industry, specializing in at-home therapy solutions for chronic diseases. With a strong focus on innovation, patient-centric care, and market expansion, the company is well-positioned for future growth. However, investors should carefully consider the associated risks before making investment decisions. Overall, Tactile Medical’s commitment to improving patient outcomes and its strategic initiatives make it a compelling choice in the healthcare sector.